German parliament debates health-insurance funding for non-invasive prenatal screening
Lawmakers from the Union, SPD, Greens and Left are clashing over whether health insurers should continue to cover the non-invasive prenatal test for trisomy detection.
Members of the Union, SPD, Greens and Left are engaged in a contentious debate in the Bundestag over the non-invasive prenatal test that screens for trisomy conditions using a simple blood draw. The discussion focuses on concerns that pregnant women may request the test too frequently, potentially burdening the statutory health insurance system. While some legislators argue for limiting reimbursement to curb expenses, others emphasize the test’s importance for early diagnosis and parental decision-making.
The parties have not yet agreed on a policy change, leaving the future of insurance coverage uncertain. The dispute reflects broader tensions about healthcare spending and preventive medicine in Germany. Observers note that the outcome could influence how prenatal screening is accessed nationwide.
